RI
PTCT icon

Redwood Investments’s PTC Therapeutics PTCT Stock Holding History

Redwood Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-245,578
Closed -$9.99M – 123
2023
Q2 		$9.99M Buy
245,578
+2,939
+1% +$144K 1.22% 39
2023
Q1 		$11.8M Buy
242,639
+59,973
+33% +$2.74M 1.5% 26
2022
Q4 		$6.97M Sell
182,666
-197,423
-52% -$8.21M 0.93% 48
2022
Q3 		$19.1M Sell
380,089
-91,889
-19% -$4.5M 2.56% 6
2022
Q2 		$18.9M Buy
471,978
+116,317
+33% +$4.08M 2.1% 13
2022
Q1 		$13.3M Buy
355,661
+1
+0% +$39 1.26% 36
2021
Q4 		$14.2M Sell
355,660
-2,533
-0.7% -$96.9K 1.12% 35
2021
Q3 		$13.3M Sell
358,193
-23,845
-6% -$979K 1.11% 39
2021
Q2 		$16.1M Sell
382,038
-2,976
-0.8% -$128K 1.3% 33
2021
Q1 		$18.2M Buy
385,014
+20,177
+6% +$1.2M 1.6% 26
2020
Q4 		$22.3M Buy
364,837
+139,482
+62% +$8.22M 1.89% 16
2020
Q3 		$10.5M Sell
225,355
-12,510
-5% -$616K 0.89% 54
2020
Q2 		$12.1M Buy
237,865
+44,912
+23% +$2.21M 1.07% 45
2020
Q1 		$8.61M Buy
+192,953
New +$9.71M 1.02% 47

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redwood Investments's PTCT Position: Q3 2023 in Review

Redwood Investments sold out of PTC Therapeutics (PTCT) in Q3 2023, closing a stake of 245,578 shares — an estimated $9.99M sold.

Redwood Investments first reported a position in PTCT in Q1 2020 and held it in 14 quarters. The position peaked at $22.3M in Q4 2020. 179 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

  • Redwood Investments reported no remaining PTC Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Redwood Investments sold 245,578 PTC Therapeutics shares in Q3 2023, an estimated $9.99M.
  • Redwood Investments first reported a position in PTC Therapeutics in Q1 2020 and held it in 14 quarters.
  • Redwood Investments's PTC Therapeutics position peaked at $22.3M in Q4 2020.
  • 179 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on Redwood Investments's 13F filing for Q3 2023, filed 24 Oct 2023.